Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients

69Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It is suggested that activation and differentiation of T-helper cells are required for peri-operative anti-tumor and anti-infection immunity. The present study aimed to evaluate whether propofol stimulates the activation and differentiation of these cells in patients undergoing pulmonary lobectomy for non-small-cell lung cancer. Thirty patients were randomly allocated to receive propofol or isoflurane throughout surgery. The CD4+CD28+ percentage (p < 0.0001) and the ratio of interferon-γ:interleukin-4 (p = 0.001) all increased with propofol but showed no change with isoflurane. In contrast, cortisol increased with isoflurane (p < 0.0001) but not with propofol over time (p = 0.06). We conclude that propofol promotes activation and differentiation of peripheral T-helper cells. © 2010 The Association of Anaesthetists of Great Britain and Ireland.

Cite

CITATION STYLE

APA

Ren, X. F., Li, W. Z., Meng, F. Y., & Lin, C. F. (2010). Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia, 65(5), 478–482. https://doi.org/10.1111/j.1365-2044.2010.06304.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free